Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Juan Andres. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Juan Andres har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:AVTR / Avantor, Inc. | Director | 65 480 |
US:MRNA / Moderna, Inc. | See remarks | 12 803 |
US:EVLO / Evelo Biosciences, Inc. | Director | 1 810 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Juan Andres. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp AVTR / Avantor, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i AVTR / Avantor, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel AVTR / Avantor, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i AVTR / Avantor, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internkjøp EVLO / Evelo Biosciences, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i AVTR / Avantor, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel EVLO / Evelo Biosciences, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i AVTR / Avantor, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Juan Andres som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-12 |
|
4 | AVTR |
Avantor, Inc.
Common Stock |
A - Award | 17 100 | 65 480 | 35,35 | ||||
2024-05-13 |
|
4 | AVTR |
Avantor, Inc.
Common Stock |
A - Award | 8 477 | 48 380 | 21,24 | ||||
2023-05-15 |
|
4 | AVTR |
Avantor, Inc.
Common Stock |
A - Award | 9 808 | 39 903 | 32,59 | ||||
2022-12-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 12 803 | −13,51 | 180,00 | −360 000 | 2 304 540 |
2022-12-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 14 803 | 15,62 | 20,93 | 41 860 | 309 827 |
2022-12-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 12 803 | −13,51 | 201,70 | −403 400 | 2 582 365 |
2022-12-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 14 803 | 15,62 | 20,93 | 41 860 | 309 827 |
2022-12-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 12 803 | −13,51 | 195,00 | −390 000 | 2 496 585 |
2022-12-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 14 803 | 15,62 | 20,93 | 41 860 | 309 827 |
2022-12-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 12 803 | −13,51 | 172,16 | −344 320 | 2 204 164 |
2022-12-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 14 803 | 15,62 | 20,93 | 41 860 | 309 827 |
2022-12-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 12 803 | −13,51 | 173,52 | −347 040 | 2 221 577 |
2022-12-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 14 803 | 15,62 | 20,93 | 41 860 | 309 827 |
2022-11-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | −814 | 12 803 | −5,98 | 173,80 | −141 475 | 2 225 195 | |
2022-11-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | 1 808 | 13 617 | 15,31 | ||||
2022-11-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 11 809 | −14,48 | 178,01 | −356 020 | 2 102 120 |
2022-11-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 13 809 | 16,94 | 20,93 | 41 860 | 289 022 |
2022-11-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 11 809 | −14,48 | 184,25 | −368 500 | 2 175 808 |
2022-11-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 13 809 | 16,94 | 20,93 | 41 860 | 289 022 |
2022-11-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | −192 | 11 809 | −1,60 | 165,59 | −31 793 | 1 955 446 | |
2022-11-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 12 001 | −14,28 | 162,50 | −325 000 | 1 950 162 |
2022-11-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 14 001 | 16,67 | 20,93 | 41 860 | 293 041 |
2022-11-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | 435 | 12 001 | 3,76 | ||||
2022-11-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 11 566 | −14,74 | 154,20 | −308 400 | 1 783 477 |
2022-11-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 13 566 | 17,29 | 20,93 | 41 860 | 283 936 |
2022-10-31 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −4 000 | 11 566 | −25,70 | 150,00 | −600 000 | 1 734 900 |
2022-10-31 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 15 566 | 14,74 | 20,93 | 41 860 | 325 796 |
2022-10-31 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 15 566 | 14,74 | 20,93 | 41 860 | 325 796 |
2022-08-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | −839 | 11 566 | −6,76 | 135,81 | −113 947 | 1 570 809 | |
2022-08-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | 1 807 | 12 405 | 17,05 | ||||
2022-08-19 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 10 598 | −15,88 | 165,24 | −330 480 | 1 751 214 |
2022-08-19 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 12 598 | 18,87 | 20,93 | 41 860 | 263 676 |
2022-08-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 10 598 | −15,88 | 174,09 | −348 180 | 1 845 006 |
2022-08-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 12 598 | 18,87 | 20,93 | 41 860 | 263 676 |
2022-08-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | −204 | 10 598 | −1,89 | 173,66 | −35 427 | 1 840 480 | |
2022-08-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | 435 | 10 802 | 4,20 | ||||
2022-08-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 10 367 | −16,17 | 167,99 | −335 980 | 1 741 552 |
2022-08-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 12 367 | 19,29 | 20,93 | 41 860 | 258 841 |
2022-07-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 10 367 | −16,17 | 161,00 | −322 000 | 1 669 087 |
2022-07-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 12 367 | 19,29 | 20,93 | 41 860 | 258 841 |
2022-07-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 10 367 | −16,17 | 167,00 | −334 000 | 1 731 289 |
2022-07-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 12 367 | 19,29 | 20,93 | 41 860 | 258 841 |
2022-07-15 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 10 367 | −16,17 | 168,88 | −337 760 | 1 750 779 |
2022-07-15 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 12 367 | 19,29 | 20,93 | 41 860 | 258 841 |
2022-07-08 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 10 367 | −16,17 | 154,85 | −309 700 | 1 605 330 |
2022-07-08 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 12 367 | 19,29 | 20,93 | 41 860 | 258 841 |
2022-07-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −6 000 | 10 367 | −36,66 | 150,00 | −900 000 | 1 555 050 |
2022-07-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 16 367 | 13,92 | 20,93 | 41 860 | 342 561 |
2022-07-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 16 367 | 13,92 | 20,93 | 41 860 | 342 561 |
2022-07-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 14 367 | 16,17 | 20,93 | 41 860 | 300 701 |
2022-06-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 000 | 10 367 | −49,10 | 150,00 | −1 500 000 | 1 555 050 |
2022-06-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 629 | 20 367 | 3,19 | 14,22 | 8 944 | 289 619 |
2022-06-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 19 738 | 11,28 | 20,93 | 41 860 | 413 116 |
2022-06-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 19 738 | 11,28 | 20,93 | 41 860 | 413 116 |
2022-06-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 17 738 | 12,71 | 20,93 | 41 860 | 371 256 |
2022-06-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 15 738 | 14,56 | 20,93 | 41 860 | 329 396 |
2022-06-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 1 371 | 11 738 | 13,22 | 20,93 | 28 695 | 245 676 |
2022-06-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | −749 | 10 367 | −6,74 | 145,40 | −108 904 | 1 507 360 | |
2022-06-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | 1 807 | 11 116 | 19,41 | 135,80 | 245 391 | 1 509 553 | |
2022-05-16 |
|
4 | AVTR |
Avantor, Inc.
Common Stock |
A - Award | 6 693 | 30 095 | 28,60 | ||||
2022-05-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | −195 | 9 309 | −2,05 | 133,71 | −26 074 | 1 244 742 | |
2022-05-11 |
|
4 | MRNA |
Moderna, Inc.
Restricted Stock Units |
M - Exercise | −435 | 4 788 | −8,33 | ||||
2022-05-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | 435 | 9 504 | 4,80 | 134,40 | 58 464 | 1 277 338 | |
2022-05-06 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 629 | −76,07 | |||
2022-05-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 9 069 | −18,07 | 153,23 | −306 460 | 1 389 643 |
2022-05-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 11 069 | 22,05 | 14,22 | 28 440 | 157 401 |
2022-05-02 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 2 629 | −43,21 | |||
2022-05-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 9 069 | −18,07 | 150,00 | −300 000 | 1 360 350 |
2022-05-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 11 069 | 22,05 | 14,22 | 28 440 | 157 401 |
2022-04-22 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 4 629 | −30,17 | |||
2022-04-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 9 069 | −18,07 | 153,00 | −306 000 | 1 387 557 |
2022-04-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 11 069 | 22,05 | 14,22 | 28 440 | 157 401 |
2022-04-15 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 6 629 | −23,18 | |||
2022-04-15 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 9 069 | −18,07 | 158,37 | −316 740 | 1 436 258 |
2022-04-15 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 11 069 | 22,05 | 14,22 | 28 440 | 157 401 |
2022-04-08 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 8 629 | −18,82 | |||
2022-04-08 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 9 069 | −18,07 | 157,50 | −315 000 | 1 428 368 |
2022-04-08 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 11 069 | 22,05 | 14,22 | 28 440 | 157 401 |
2022-04-05 |
|
4 | AVTR |
Avantor, Inc.
Common Stock |
A - Award | 1 215 | 23 402 | 5,48 | ||||
2022-04-01 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 10 629 | −15,84 | |||
2022-04-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 9 069 | −18,07 | 182,79 | −365 580 | 1 657 723 |
2022-04-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 11 069 | 22,05 | 14,22 | 28 440 | 157 401 |
2022-03-25 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 12 629 | −13,67 | |||
2022-03-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 9 069 | −18,07 | 184,66 | −369 320 | 1 674 682 |
2022-03-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 11 069 | 22,05 | 14,22 | 28 440 | 157 401 |
2022-03-18 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 14 629 | −12,03 | |||
2022-03-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 9 069 | −18,07 | 150,01 | −300 020 | 1 360 441 |
2022-03-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 11 069 | 22,05 | 14,22 | 28 440 | 157 401 |
2022-03-15 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 16 629 | −10,74 | |||
2022-03-15 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 9 069 | −18,07 | 150,00 | −300 000 | 1 360 350 |
2022-03-15 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 11 069 | 22,05 | 14,22 | 28 440 | 157 401 |
2022-03-03 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 18 629 | −9,70 | |||
2022-03-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 9 069 | −18,07 | 150,00 | −300 000 | 1 360 350 |
2022-03-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 11 069 | 22,05 | 14,22 | 28 440 | 157 401 |
2022-03-03 |
|
4 | MRNA |
Moderna, Inc.
Restricted Stock Units |
A - Award | 8 019 | 8 019 | |||||
2022-03-03 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
A - Award | 32 525 | 32 525 | |||||
2022-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | −6 365 | 9 069 | −41,24 | 152,52 | −970 822 | 1 383 249 | |
2022-03-02 |
|
4 | MRNA |
Moderna, Inc.
Restricted Stock Units |
M - Exercise | −14 462 | 14 462 | −50,00 | ||||
2022-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | 14 462 | 15 434 | 1 487,86 | ||||
2022-02-25 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 20 629 | −8,84 | |||
2022-02-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 972 | −67,29 | 150,00 | −300 000 | 145 800 |
2022-02-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 2 972 | 205,76 | 14,22 | 28 440 | 42 262 |
2022-02-18 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 22 629 | −8,12 | |||
2022-02-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 972 | −67,29 | 150,00 | −300 000 | 145 800 |
2022-02-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 2 972 | 205,76 | 14,22 | 28 440 | 42 262 |
2022-02-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | −768 | 972 | −44,14 | 158,89 | −122 029 | 154 443 | |
2022-02-11 |
|
4 | MRNA |
Moderna, Inc.
Restricted Stock Units |
M - Exercise | −1 740 | 5 223 | −24,99 | ||||
2022-02-11 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 24 629 | −7,51 | |||
2022-02-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | 1 740 | 1 740 | |||||
2022-02-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 0 | −100,00 | 154,26 | −308 520 | |
2022-02-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 2 000 | 14,22 | 28 440 | 28 440 | |
2022-02-04 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 000 | 26 629 | −6,99 | |||
2022-02-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 000 | 0 | −100,00 | 170,89 | −341 780 | |
2022-02-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 2 000 | 2 000 | 14,22 | 28 440 | 28 440 | |
2022-01-04 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 0 | −100,00 | |||
2022-01-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 249,88 | −1 249 400 | |
2022-01-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-12-30 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 5 000 | −50,00 | |||
2021-12-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 240,00 | −1 200 000 | |
2021-12-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-12-29 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 10 000 | −33,33 | |||
2021-12-29 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 10 000 | −33,33 | |||
2021-12-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 000 | 0 | −100,00 | 243,10 | −2 431 000 | |
2021-12-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 10 000 | 100,00 | 12,21 | 61 050 | 122 100 |
2021-12-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 10 000 | 100,00 | 12,21 | 61 050 | 122 100 |
2021-12-23 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 20 000 | −20,00 | |||
2021-12-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 264,26 | −1 321 300 | |
2021-12-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-12-21 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 25 000 | −16,67 | |||
2021-12-21 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 28 629 | −25,89 | |||
2021-12-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −15 000 | 0 | −100,00 | 320,97 | −4 814 550 | |
2021-12-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 15 000 | 50,00 | 12,21 | 61 050 | 183 150 |
2021-12-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 14,22 | 142 200 | 142 200 | |
2021-12-21 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 30 000 | −14,29 | |||
2021-12-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 275,68 | −1 378 400 | |
2021-12-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-12-17 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 35 000 | −12,50 | |||
2021-12-17 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 272,11 | −1 360 550 | |
2021-12-17 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-12-14 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 40 000 | −11,11 | |||
2021-12-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 257,01 | −1 285 050 | |
2021-12-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-12-14 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 45 000 | −10,00 | |||
2021-12-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 235,00 | −1 175 000 | |
2021-12-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-12-10 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 50 000 | −9,09 | |||
2021-12-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 282,35 | −1 411 750 | |
2021-12-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-12-07 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 55 000 | −8,33 | |||
2021-12-07 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 38 629 | −20,56 | |||
2021-12-07 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −15 000 | 0 | −100,00 | 280,60 | −4 209 000 | |
2021-12-07 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 15 000 | 50,00 | 12,21 | 61 050 | 183 150 |
2021-12-07 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 14,22 | 142 200 | 142 200 | |
2021-12-07 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 60 000 | −7,69 | |||
2021-12-07 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 318,40 | −1 592 000 | |
2021-12-07 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-12-03 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 65 000 | −7,14 | |||
2021-12-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 329,91 | −1 649 550 | |
2021-12-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-11-30 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 70 000 | −6,67 | |||
2021-11-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 370,38 | −1 851 900 | |
2021-11-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-11-30 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 75 000 | −6,25 | |||
2021-11-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 319,62 | −1 598 100 | |
2021-11-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-11-26 |
|
4 | MRNA |
Moderna, Inc.
Stock Option(Right to Buy) |
M - Exercise | X | −5 000 | 80 000 | −5,88 | |||
2021-11-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 273,01 | −1 365 050 | |
2021-11-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-11-23 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | −5 000 | 85 000 | −5,56 | ||||
2021-11-23 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | −10 000 | 48 629 | −17,06 | ||||
2021-11-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −15 000 | 0 | −100,00 | 268,18 | −4 022 700 | |
2021-11-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 15 000 | 50,00 | 12,21 | 61 050 | 183 150 |
2021-11-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 14,22 | 142 200 | 142 200 | |
2021-11-23 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | −5 000 | 90 000 | −5,26 | ||||
2021-11-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 265,71 | −1 328 550 | |
2021-11-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-11-19 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 95 000 | −5,00 | |||
2021-11-19 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 234,57 | −1 172 850 | |
2021-11-19 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-11-16 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 100 000 | −4,76 | |||
2021-11-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 231,01 | −1 155 050 | |
2021-11-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-11-16 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 105 000 | −4,55 | |||
2021-11-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 225,86 | −1 129 300 | |
2021-11-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-11-12 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 110 000 | −4,35 | |||
2021-11-12 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 230,00 | −1 150 000 | |
2021-11-12 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-11-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 115 000 | −4,17 | |||
2021-11-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 58 629 | −14,57 | |||
2021-11-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −15 000 | 0 | −100,00 | 233,13 | −3 496 950 | |
2021-11-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 15 000 | 50,00 | 12,21 | 61 050 | 183 150 |
2021-11-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 14,22 | 142 200 | 142 200 | |
2021-11-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 120 000 | −4,00 | |||
2021-11-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 240,00 | −1 200 000 | |
2021-11-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-11-05 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 125 000 | −3,85 | |||
2021-11-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 350,00 | −1 750 000 | |
2021-11-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-11-02 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 130 000 | −3,70 | |||
2021-11-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 335,00 | −1 675 000 | |
2021-11-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-11-02 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 135 000 | −3,57 | |||
2021-11-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 344,49 | −1 722 450 | |
2021-11-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-10-29 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 140 000 | −3,45 | |||
2021-10-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 344,25 | −1 721 250 | |
2021-10-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-10-26 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −9 822 | 145 000 | −6,34 | |||
2021-10-26 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 154 822 | −3,13 | |||
2021-10-26 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −178 | 68 629 | −0,26 | |||
2021-10-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −15 000 | 0 | −100,00 | 327,36 | −4 910 400 | |
2021-10-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 9 822 | 15 000 | 189,69 | 12,21 | 119 927 | 183 150 |
2021-10-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 178 | 2 808,99 | 12,21 | 61 050 | 63 223 |
2021-10-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 178 | 178 | 14,22 | 2 531 | 2 531 | |
2021-10-26 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 159 822 | −3,03 | |||
2021-10-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 333,00 | −1 665 000 | |
2021-10-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-10-22 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 164 822 | −2,94 | |||
2021-10-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 333,90 | −1 669 500 | |
2021-10-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-10-19 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 169 822 | −2,86 | |||
2021-10-19 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 322,26 | −1 611 300 | |
2021-10-19 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-10-19 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 174 822 | −2,78 | |||
2021-10-19 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 341,25 | −1 706 250 | |
2021-10-19 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-10-14 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 179 822 | −2,71 | |||
2021-10-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 314,90 | −1 574 500 | |
2021-10-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-10-12 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 184 822 | −5,13 | |||
2021-10-12 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 194 822 | −2,50 | |||
2021-10-12 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −15 000 | 0 | −100,00 | 300,00 | −4 500 000 | |
2021-10-12 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 15 000 | 200,00 | 12,21 | 122 100 | 183 150 |
2021-10-12 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-10-12 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 199 822 | −2,44 | |||
2021-10-12 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 310,44 | −1 552 200 | |
2021-10-12 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-10-08 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 204 822 | −2,38 | |||
2021-10-08 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 318,23 | −1 591 150 | |
2021-10-08 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-10-05 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 209 822 | −2,33 | |||
2021-10-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 307,54 | −1 537 700 | |
2021-10-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-10-05 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 214 822 | −2,27 | |||
2021-10-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 359,00 | −1 795 000 | |
2021-10-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-10-01 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 219 822 | −2,22 | |||
2021-10-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 393,44 | −1 967 200 | |
2021-10-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-09-28 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 224 822 | −4,26 | |||
2021-09-28 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 234 822 | −2,08 | |||
2021-09-28 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −15 000 | 0 | −100,00 | 429,38 | −6 440 700 | |
2021-09-28 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 15 000 | 200,00 | 12,21 | 122 100 | 183 150 |
2021-09-28 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-09-28 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 239 822 | −2,04 | |||
2021-09-28 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 448,04 | −2 240 200 | |
2021-09-28 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-09-24 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 244 822 | −2,00 | |||
2021-09-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 433,00 | −2 165 000 | |
2021-09-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-09-21 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 249 822 | −1,96 | |||
2021-09-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 417,62 | −2 088 100 | |
2021-09-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-09-21 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 254 822 | −1,92 | |||
2021-09-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 438,24 | −2 191 200 | |
2021-09-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-09-17 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 259 822 | −1,89 | |||
2021-09-17 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 427,13 | −2 135 650 | |
2021-09-17 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-09-14 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 264 822 | −3,64 | |||
2021-09-14 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 274 822 | −1,79 | |||
2021-09-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −15 000 | 0 | −100,00 | 447,41 | −6 711 150 | |
2021-09-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 15 000 | 200,00 | 12,21 | 122 100 | 183 150 |
2021-09-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-09-14 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 279 822 | −1,76 | |||
2021-09-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 461,85 | −2 309 250 | |
2021-09-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-09-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 284 822 | −1,73 | |||
2021-09-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 433,72 | −2 168 600 | |
2021-09-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-09-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 289 822 | −1,70 | |||
2021-09-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 409,59 | −2 047 950 | |
2021-09-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-09-07 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 294 822 | −1,67 | |||
2021-09-07 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 392,35 | −1 961 750 | |
2021-09-07 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-09-03 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 299 822 | −1,64 | |||
2021-09-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 381,82 | −1 909 100 | |
2021-09-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-08-31 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 304 822 | −3,18 | |||
2021-08-31 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 314 822 | −1,56 | |||
2021-08-31 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −15 000 | 0 | −100,00 | 368,93 | −5 533 950 | |
2021-08-31 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 15 000 | 200,00 | 12,21 | 122 100 | 183 150 |
2021-08-31 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-08-31 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 319 822 | −1,54 | |||
2021-08-31 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 398,12 | −1 990 600 | |
2021-08-31 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-08-27 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 324 822 | −1,52 | |||
2021-08-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 391,59 | −1 957 950 | |
2021-08-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-08-24 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 329 822 | −1,49 | |||
2021-08-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 390,11 | −1 950 550 | |
2021-08-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-08-24 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 334 822 | −1,47 | |||
2021-08-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 374,88 | −1 874 400 | |
2021-08-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-08-20 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 339 822 | −1,45 | |||
2021-08-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 407,00 | −2 035 000 | |
2021-08-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-08-18 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 344 822 | −2,82 | |||
2021-08-18 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 354 822 | −1,39 | |||
2021-08-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −15 000 | 0 | −100,00 | 379,27 | −5 689 050 | |
2021-08-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 15 000 | 200,00 | 12,21 | 122 100 | 183 150 |
2021-08-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-08-16 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 359 822 | −1,37 | |||
2021-08-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 405,00 | −2 025 000 | |
2021-08-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-08-13 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 364 822 | −1,35 | |||
2021-08-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 443,34 | −2 216 700 | |
2021-08-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-08-10 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 369 822 | −1,33 | |||
2021-08-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 411,50 | −2 057 500 | |
2021-08-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-08-10 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 374 822 | −1,32 | |||
2021-08-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 410,30 | −2 051 500 | |
2021-08-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-08-06 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 379 822 | −1,30 | |||
2021-08-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 384,85 | −1 924 250 | |
2021-08-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-08-03 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 384 822 | −2,53 | |||
2021-08-03 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 394 822 | −1,25 | |||
2021-08-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −15 000 | 0 | −100,00 | 360,15 | −5 402 250 | |
2021-08-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 15 000 | 200,00 | 12,21 | 122 100 | 183 150 |
2021-08-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-08-03 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 399 822 | −1,24 | |||
2021-08-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 346,90 | −1 734 500 | |
2021-08-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-07-30 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 404 822 | −1,22 | |||
2021-07-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 332,92 | −1 664 600 | |
2021-07-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-07-27 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 409 822 | −1,21 | |||
2021-07-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 351,99 | −1 759 950 | |
2021-07-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-07-27 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 414 822 | −1,19 | |||
2021-07-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 330,90 | −1 654 500 | |
2021-07-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-07-23 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 419 822 | −1,18 | |||
2021-07-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 299,00 | −1 495 000 | |
2021-07-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-07-20 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 424 822 | −2,30 | |||
2021-07-20 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 434 822 | −1,14 | |||
2021-07-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −15 000 | 0 | −100,00 | 284,40 | −4 266 000 | |
2021-07-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 10 000 | 15 000 | 200,00 | 12,21 | 122 100 | 183 150 |
2021-07-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-07-20 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 439 822 | −1,12 | |||
2021-07-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 276,51 | −1 382 550 | |
2021-07-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-07-16 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 444 822 | −1,11 | |||
2021-07-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 237,22 | −1 186 100 | |
2021-07-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-07-14 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 449 822 | −1,10 | |||
2021-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 230,71 | −1 153 550 | |
2021-07-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-07-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 454 822 | −1,09 | |||
2021-07-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 231,76 | −1 158 800 | |
2021-07-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-07-08 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 459 822 | −1,08 | |||
2021-07-08 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 229,62 | −1 148 100 | |
2021-07-08 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-07-02 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 464 822 | −1,06 | |||
2021-07-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 237,00 | −1 185 000 | |
2021-07-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-06-30 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 469 822 | −1,05 | |||
2021-06-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 223,00 | −1 115 000 | |
2021-06-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-06-25 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 474 822 | −1,04 | |||
2021-06-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 219,65 | −1 098 250 | |
2021-06-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-06-23 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 479 822 | −1,03 | |||
2021-06-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 200,86 | −1 004 300 | |
2021-06-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-06-21 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 484 822 | −1,02 | |||
2021-06-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 200,00 | −1 000 000 | |
2021-06-21 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-06-15 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 489 822 | −1,01 | |||
2021-06-15 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 213,32 | −1 066 600 | |
2021-06-15 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-06-11 |
|
4 | EVLO |
Evelo Biosciences, Inc.
Stock Option (Right to Buy) |
A - Award | 1 810 | 1 810 | |||||
2021-06-11 |
|
4 | EVLO |
Evelo Biosciences, Inc.
Stock Option (Right to Buy) |
A - Award | 15 690 | 15 690 | |||||
2021-06-11 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 494 822 | −1,00 | |||
2021-06-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 212,30 | −1 061 500 | |
2021-06-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-06-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 499 822 | −0,99 | |||
2021-06-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 207,04 | −1 035 200 | |
2021-06-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-06-03 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 504 822 | −0,98 | |||
2021-06-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 183,90 | −919 500 | |
2021-06-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-06-03 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 509 822 | −0,97 | |||
2021-06-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 184,08 | −920 400 | |
2021-06-03 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-05-27 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 514 822 | −0,96 | |||
2021-05-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 168,70 | −843 500 | |
2021-05-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-05-25 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 519 822 | −0,95 | |||
2021-05-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 162,45 | −812 250 | |
2021-05-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-05-20 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 524 822 | −0,94 | |||
2021-05-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 155,74 | −778 700 | |
2021-05-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-05-18 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 529 822 | −0,93 | |||
2021-05-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 159,23 | −796 150 | |
2021-05-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-05-13 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 534 822 | −0,93 | |||
2021-05-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 154,11 | −770 550 | |
2021-05-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-05-11 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 539 822 | −0,92 | |||
2021-05-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 164,38 | −821 900 | |
2021-05-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-05-06 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 544 822 | −0,91 | |||
2021-05-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 178,34 | −891 700 | |
2021-05-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-05-04 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 549 822 | −0,90 | |||
2021-05-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 183,66 | −918 300 | |
2021-05-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-04-29 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 554 822 | −0,89 | |||
2021-04-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 182,32 | −911 600 | |
2021-04-29 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-04-27 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 559 822 | −0,89 | |||
2021-04-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 171,77 | −858 850 | |
2021-04-27 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-04-22 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 564 822 | −0,88 | |||
2021-04-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 158,60 | −793 000 | |
2021-04-22 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-04-20 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 569 822 | −0,87 | |||
2021-04-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 166,17 | −830 850 | |
2021-04-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-04-16 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 574 822 | −0,86 | |||
2021-04-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 153,75 | −768 750 | |
2021-04-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-04-13 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 579 822 | −0,85 | |||
2021-04-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 142,46 | −712 300 | |
2021-04-13 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-04-08 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 584 822 | −0,85 | |||
2021-04-08 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 131,63 | −658 150 | |
2021-04-08 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-04-06 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 589 822 | −0,84 | |||
2021-04-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 132,63 | −663 150 | |
2021-04-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-04-01 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 594 822 | −0,83 | |||
2021-04-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 121,10 | −605 500 | |
2021-04-01 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-03-30 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 599 822 | −0,83 | |||
2021-03-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 130,05 | −650 250 | |
2021-03-30 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-03-25 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 604 822 | −0,82 | |||
2021-03-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 137,07 | −685 350 | |
2021-03-25 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-03-23 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 609 822 | −0,81 | |||
2021-03-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 144,19 | −720 950 | |
2021-03-23 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-03-18 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 614 822 | −0,81 | |||
2021-03-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 149,78 | −748 900 | |
2021-03-18 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-03-16 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 619 822 | −0,80 | |||
2021-03-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 137,00 | −685 000 | |
2021-03-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-03-11 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 624 822 | −0,79 | |||
2021-03-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 133,24 | −666 200 | |
2021-03-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 629 822 | −0,79 | |||
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 129,41 | −647 050 | |
2021-03-10 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-03-04 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 634 822 | −0,78 | |||
2021-03-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 145,60 | −728 000 | |
2021-03-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 639 822 | −0,78 | |||
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 153,84 | −769 200 | |
2021-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-03-01 |
|
4 | AVTR |
Avantor, Inc.
Common Stock |
A - Award | 7 236 | 22 187 | 48,40 | ||||
2021-02-24 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 644 822 | −0,77 | |||
2021-02-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 166,63 | −833 150 | |
2021-02-24 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-02-17 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 649 822 | −0,76 | |||
2021-02-17 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 182,80 | −914 000 | |
2021-02-17 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-02-11 |
|
4 | MRNA |
Moderna, Inc.
Restricted Stock Units |
A - Award | 6 963 | 6 963 | |||||
2021-02-11 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
A - Award | 32 023 | 32 023 | |||||
2021-02-09 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 654 822 | −0,76 | |||
2021-02-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 176,98 | −884 900 | |
2021-02-09 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 659 822 | −0,75 | |||
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 172,99 | −864 950 | |
2021-02-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-01-26 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 664 822 | −0,75 | |||
2021-01-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 138,77 | −693 850 | |
2021-01-26 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-01-20 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 669 822 | −0,74 | |||
2021-01-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 121,88 | −609 400 | |
2021-01-20 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-01-12 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 674 822 | −0,74 | |||
2021-01-12 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 112,83 | −564 150 | |
2021-01-12 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2021-01-05 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 679 822 | −0,73 | |||
2021-01-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 107,15 | −535 750 | |
2021-01-05 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 12,21 | 61 050 | 61 050 | |
2020-06-18 |
|
4 | EVLO |
Evelo Biosciences, Inc.
Stock Option (Right to Buy) |
A - Award | 15 690 | 15 690 | |||||
2020-06-04 |
|
4/A | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 934 | 0 | −100,00 | 49,69 | −195 480 | |
2020-06-04 |
|
4/A | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 300 | 0 | −100,00 | 66,89 | −86 957 | |
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −127 500 | 684 822 | −15,70 | |||
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 300 | 0 | −100,00 | 66,89 | −86 957 | |
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −15 640 | 1 300 | −92,33 | 66,27 | −1 036 463 | 86 151 |
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −46 517 | 16 940 | −73,30 | 65,28 | −3 036 630 | 1 105 843 |
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −38 089 | 63 457 | −37,51 | 64,44 | −2 454 455 | 4 089 169 |
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −16 183 | 101 546 | −13,75 | 63,17 | −1 022 280 | 6 414 661 |
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −8 371 | 117 729 | −6,64 | 62,41 | −522 434 | 7 347 467 |
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −1 400 | 126 100 | −1,10 | 61,16 | −85 624 | 7 712 276 |
2020-05-14 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 127 500 | 127 500 | 12,21 | 1 556 775 | 1 556 775 | |
2020-05-04 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −25 000 | 812 322 | −2,99 | |||
2020-05-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 934 | 0 | −100,00 | 49,69 | −195 480 | |
2020-05-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 984 | 3 934 | −50,32 | 48,87 | −194 698 | 192 255 |
2020-05-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 784 | 7 918 | −57,66 | 47,82 | −515 691 | 378 639 |
2020-05-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −6 298 | 18 702 | −25,19 | 46,91 | −295 439 | 877 311 |
2020-05-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 25 000 | 25 000 | 12,21 | 305 250 | 305 250 | |
2020-04-16 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −23 403 | 837 322 | −2,72 | |||
2020-04-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −9 944 | 0 | −100,00 | 37,78 | −375 684 | |
2020-04-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −8 852 | 9 944 | −47,10 | 36,91 | −326 727 | 367 033 |
2020-04-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −4 607 | 18 796 | −19,69 | 36,04 | −166 036 | 677 408 |
2020-04-16 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 23 403 | 23 403 | 12,21 | 285 751 | 285 751 | |
2020-04-08 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −300 | 860 725 | −0,03 | |||
2020-04-08 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −300 | 0 | −100,00 | 35,13 | −10 539 | |
2020-04-08 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 300 | 300 | 12,21 | 3 663 | 3 663 | |
2020-04-06 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −13 697 | 861 025 | −1,57 | |||
2020-04-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −13 697 | 0 | −100,00 | 35,09 | −480 628 | |
2020-04-06 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 13 697 | 13 697 | 12,21 | 167 240 | 167 240 | |
2020-03-19 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −15 281 | 874 722 | −1,72 | |||
2020-03-19 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −8 187 | 0 | −100,00 | 31,75 | −259 937 | |
2020-03-19 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −7 094 | 8 187 | −46,42 | 31,06 | −220 340 | 254 288 |
2020-03-19 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 15 281 | 15 281 | 12,21 | 186 581 | 186 581 | |
2020-03-19 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −16 317 | 890 003 | −1,80 | |||
2020-03-19 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −730 | 0 | −100,00 | 32,50 | −23 725 | |
2020-03-19 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −5 581 | 730 | −88,43 | 31,98 | −178 480 | 23 345 |
2020-03-19 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −10 006 | 6 311 | −61,32 | 30,47 | −304 883 | 192 296 |
2020-03-19 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 16 317 | 16 317 | 12,21 | 199 231 | 199 231 | |
2020-03-11 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −104 | 906 320 | −0,01 | |||
2020-03-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −104 | 0 | −100,00 | 30,00 | −3 120 | |
2020-03-11 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 104 | 104 | 12,21 | 1 270 | 1 270 | |
2020-03-04 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −3 001 | 906 424 | −0,33 | |||
2020-03-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 001 | 0 | −100,00 | 30,12 | −90 390 | |
2020-03-04 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 3 001 | 3 001 | 12,21 | 36 642 | 36 642 | |
2020-03-02 |
|
4 | MRNA |
Moderna, Inc.
Restricted Stock Units |
A - Award | 28 924 | 28 924 | |||||
2020-03-02 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
A - Award | 161 120 | 161 120 | |||||
2020-03-02 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −8 006 | 909 425 | −0,87 | |||
2020-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 31,95 | −15 975 | |
2020-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −3 272 | 500 | −86,74 | 33,05 | −108 140 | 16 525 |
2020-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 188 | 3 772 | −36,71 | 34,10 | −74 611 | 128 625 |
2020-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
S - Sale | X | −2 046 | 5 960 | −25,56 | 34,81 | −71 221 | 207 468 |
2020-03-02 |
|
4 | MRNA |
Moderna, Inc.
Common Stock |
M - Exercise | X | 8 006 | 8 006 | 12,21 | 97 753 | 97 753 | |
2020-02-25 |
|
4 | AVTR |
Avantor, Inc.
Common Stock |
A - Award | 11 319 | 14 951 | 311,65 | ||||
2019-12-06 |
|
4 | EVLO |
Evelo Biosciences, Inc.
Stock Option (Right to Buy) |
A - Award | 31 380 | 31 380 | |||||
2019-09-24 |
|
4 | AVTR |
Avantor, Inc.
Common Stock |
A - Award | 3 632 | 0 | −100,00 | ||||
2019-03-11 |
|
4 | MRNA |
Moderna, Inc.
Stock Option (Right to Buy) |
A - Award | 254 396 | 254 396 |